SK281405B6 - Terapeutický prípravok na transdermálnu aplikáciu účinných látok - Google Patents
Terapeutický prípravok na transdermálnu aplikáciu účinných látok Download PDFInfo
- Publication number
- SK281405B6 SK281405B6 SK558-98A SK55898A SK281405B6 SK 281405 B6 SK281405 B6 SK 281405B6 SK 55898 A SK55898 A SK 55898A SK 281405 B6 SK281405 B6 SK 281405B6
- Authority
- SK
- Slovakia
- Prior art keywords
- active substances
- skin
- hmg
- increase
- therapeutic preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19541260A DE19541260A1 (de) | 1995-11-06 | 1995-11-06 | Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut |
PCT/EP1996/004138 WO1997017061A1 (de) | 1995-11-06 | 1996-09-21 | Therapeutische zubereitung zur transdermalen applikation von wirkstoffen durch die haut |
Publications (2)
Publication Number | Publication Date |
---|---|
SK55898A3 SK55898A3 (en) | 1998-11-04 |
SK281405B6 true SK281405B6 (sk) | 2001-03-12 |
Family
ID=7776710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK558-98A SK281405B6 (sk) | 1995-11-06 | 1996-09-21 | Terapeutický prípravok na transdermálnu aplikáciu účinných látok |
Country Status (21)
Country | Link |
---|---|
US (1) | US6379696B1 (cs) |
EP (1) | EP0859595B1 (cs) |
JP (1) | JP2001507331A (cs) |
KR (1) | KR100445940B1 (cs) |
CN (1) | CN1201385A (cs) |
AT (1) | ATE186209T1 (cs) |
AU (1) | AU716896B2 (cs) |
CZ (1) | CZ289143B6 (cs) |
DE (2) | DE19541260A1 (cs) |
ES (1) | ES2141534T3 (cs) |
GR (1) | GR3032523T3 (cs) |
IL (1) | IL124279A (cs) |
MX (1) | MX9803563A (cs) |
MY (1) | MY132407A (cs) |
NO (1) | NO982006L (cs) |
NZ (1) | NZ318783A (cs) |
PL (1) | PL326497A1 (cs) |
PT (1) | PT859595E (cs) |
SK (1) | SK281405B6 (cs) |
WO (1) | WO1997017061A1 (cs) |
ZA (1) | ZA969271B (cs) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19830732B4 (de) * | 1998-07-09 | 2008-11-13 | Lts Lohmann Therapie-Systeme Ag | Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung |
EP1335711B1 (en) * | 2000-09-08 | 2007-07-25 | Alza Corporation | Transdermal device |
US20020187169A1 (en) * | 2001-05-11 | 2002-12-12 | Shoujun Chen | Kavalactone compositions |
US7323191B2 (en) * | 2003-07-28 | 2008-01-29 | Alza Corporation | Transdermal warfarin system |
EP1731147A4 (en) * | 2004-03-31 | 2010-06-30 | Kowa Co | EXTERNAL PREPARATION |
WO2007125339A1 (en) | 2006-04-26 | 2007-11-08 | Rosemont Pharmaceuticals Ltd | Liquid oral compositions |
JP5230613B2 (ja) | 2006-05-23 | 2013-07-10 | テラコス・インコーポレイテッド | グルコース輸送体阻害剤およびその使用方法 |
US8748419B2 (en) | 2006-06-16 | 2014-06-10 | Theracos, Inc. | Treating obesity with muscarinic receptor M1 antagonists |
US7893053B2 (en) | 2006-06-16 | 2011-02-22 | Theracos, Inc. | Treating psychological conditions using muscarinic receptor M1 antagonists |
US7652767B2 (en) * | 2006-10-19 | 2010-01-26 | Sporian Microsystems, Inc. | Optical sensor with chemically reactive surface |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
US20100210932A1 (en) * | 2007-03-20 | 2010-08-19 | Bayer Healthcare Llc | Method of analyzing an analyte |
RU2492175C2 (ru) | 2007-04-02 | 2013-09-10 | Теракос, Инк. | Бензиловые производные гликозидов и способы их применения |
EP2187742B1 (en) | 2007-08-23 | 2017-10-25 | Theracos Sub, LLC | (2s,3r,4r,5s,6r)-2-(4-chloro-3-benzylphenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol derivatives for use in the treatment of diabetes |
TWI523652B (zh) | 2008-07-15 | 2016-03-01 | 泰瑞克公司 | 氘化苄基苯衍生物及使用方法 |
CN105237502A (zh) | 2008-08-22 | 2016-01-13 | 泰拉科斯萨伯有限责任公司 | 制备sglt2抑制剂的方法 |
ES2554375T3 (es) | 2008-11-25 | 2015-12-18 | University Of Rochester | Inhibidores de las MLK y métodos de uso |
EP2445506B1 (en) | 2009-06-24 | 2014-12-31 | Entarco SA | The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer |
CN103491778B (zh) | 2010-04-13 | 2017-05-31 | 雷尔玛达治疗股份有限公司 | 1‑甲基‑n‑(2,6‑二甲苯基)‑2‑哌啶甲酰胺的皮肤用药物组合物及其使用方法 |
WO2011149950A2 (en) | 2010-05-24 | 2011-12-01 | University Of Rochester | Bicyclic heteroaryl kinase inhibitors and methods of use |
WO2011153712A1 (en) | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
EP2654757A1 (en) | 2010-12-22 | 2013-10-30 | Entarco SA | The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents |
WO2012112933A1 (en) | 2011-02-18 | 2012-08-23 | The Scripps Research Institute | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate |
US10485800B2 (en) | 2012-11-30 | 2019-11-26 | The University Of Rochester | Mixed lineage kinase inhibitors for HIV/AIDS therapies |
US9420820B2 (en) | 2013-08-09 | 2016-08-23 | University Of Tsukuba | Method for isolating polyphenols from olive mill water |
EP3119394B1 (en) | 2014-03-19 | 2021-05-12 | Curza Global LLC | Compositions and methods comprising 2-(acylamino)imidazoles |
JP2020512981A (ja) | 2017-03-31 | 2020-04-30 | カーザ グローバル,リミティド ライアビリティ カンパニー | 置換2−アミノイミダゾールを含む組成物と方法 |
AU2019324170A1 (en) | 2018-08-23 | 2021-02-18 | Seagen, Inc. | Anti-TIGIT antibodies |
JP2023548538A (ja) | 2020-11-08 | 2023-11-17 | シージェン インコーポレイテッド | 併用療法 |
JP2024514816A (ja) | 2021-04-09 | 2024-04-03 | シージェン インコーポレイテッド | 抗tigit抗体を用いるがんの治療方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3634016A1 (de) * | 1986-04-17 | 1987-10-29 | Lohmann Gmbh & Co Kg | Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung |
US5211947A (en) * | 1988-12-16 | 1993-05-18 | Schering Corporation | Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor |
US5316765A (en) * | 1989-09-07 | 1994-05-31 | Karl Folkers Foundation For Biomedical And Clinical Research | Use of coenzyme Q10 in combination with HMG-CoA reductase inhibitor therapies |
WO1991015241A1 (en) * | 1990-03-30 | 1991-10-17 | Yasunori Morimoto | Percutaneously absorbable composition of narcotic and nonnarcotic analgesics |
IL109037A (en) * | 1993-03-19 | 1999-01-26 | Cellegy Pharma Inc | Preparations for causing phase separation of lipid layers and preparation of the above preparations |
DE4341444C2 (de) * | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung |
US5968983A (en) * | 1994-10-05 | 1999-10-19 | Nitrosystems, Inc | Method and formulation for treating vascular disease |
-
1995
- 1995-11-06 DE DE19541260A patent/DE19541260A1/de not_active Withdrawn
-
1996
- 1996-09-21 JP JP51777797A patent/JP2001507331A/ja active Pending
- 1996-09-21 IL IL12427997A patent/IL124279A/xx not_active IP Right Cessation
- 1996-09-21 AU AU70859/96A patent/AU716896B2/en not_active Ceased
- 1996-09-21 CN CN96198113A patent/CN1201385A/zh active Pending
- 1996-09-21 EP EP96931820A patent/EP0859595B1/de not_active Expired - Lifetime
- 1996-09-21 PT PT96931820T patent/PT859595E/pt unknown
- 1996-09-21 WO PCT/EP1996/004138 patent/WO1997017061A1/de active IP Right Grant
- 1996-09-21 NZ NZ318783A patent/NZ318783A/en unknown
- 1996-09-21 US US09/068,326 patent/US6379696B1/en not_active Expired - Lifetime
- 1996-09-21 KR KR10-1998-0703316A patent/KR100445940B1/ko not_active IP Right Cessation
- 1996-09-21 DE DE59603597T patent/DE59603597D1/de not_active Expired - Lifetime
- 1996-09-21 SK SK558-98A patent/SK281405B6/sk unknown
- 1996-09-21 PL PL96326497A patent/PL326497A1/xx unknown
- 1996-09-21 AT AT96931820T patent/ATE186209T1/de active
- 1996-09-21 CZ CZ19981366A patent/CZ289143B6/cs not_active IP Right Cessation
- 1996-09-21 ES ES96931820T patent/ES2141534T3/es not_active Expired - Lifetime
- 1996-11-04 MY MYPI96004590A patent/MY132407A/en unknown
- 1996-11-05 ZA ZA969271A patent/ZA969271B/xx unknown
-
1998
- 1998-05-04 NO NO982006A patent/NO982006L/no not_active Application Discontinuation
- 1998-05-06 MX MX9803563A patent/MX9803563A/es not_active IP Right Cessation
-
2000
- 2000-01-31 GR GR20000400219T patent/GR3032523T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN1201385A (zh) | 1998-12-09 |
SK55898A3 (en) | 1998-11-04 |
KR19990067320A (ko) | 1999-08-16 |
EP0859595B1 (de) | 1999-11-03 |
CZ136698A3 (cs) | 1998-07-15 |
NZ318783A (en) | 1999-04-29 |
NO982006D0 (no) | 1998-05-04 |
IL124279A (en) | 2003-07-06 |
NO982006L (no) | 1998-05-04 |
PL326497A1 (en) | 1998-09-28 |
MX9803563A (es) | 1998-09-30 |
WO1997017061A1 (de) | 1997-05-15 |
ES2141534T3 (es) | 2000-03-16 |
DE59603597D1 (de) | 1999-12-09 |
JP2001507331A (ja) | 2001-06-05 |
KR100445940B1 (ko) | 2005-09-30 |
PT859595E (pt) | 2000-04-28 |
MY132407A (en) | 2007-10-31 |
ATE186209T1 (de) | 1999-11-15 |
US6379696B1 (en) | 2002-04-30 |
GR3032523T3 (en) | 2000-05-31 |
ZA969271B (en) | 1997-06-03 |
AU7085996A (en) | 1997-05-29 |
CZ289143B6 (cs) | 2001-11-14 |
DE19541260A1 (de) | 1997-05-07 |
AU716896B2 (en) | 2000-03-09 |
EP0859595A1 (de) | 1998-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK281405B6 (sk) | Terapeutický prípravok na transdermálnu aplikáciu účinných látok | |
EP2521453B1 (en) | Combinations of vitamin d and a statin for the treatment of migraine headaches | |
US8435556B2 (en) | Transdermal delivery of cannabidiol | |
JP5184342B2 (ja) | 外用の医薬組成物 | |
JP5184341B2 (ja) | 外用の医薬組成物 | |
US4321257A (en) | Potentiated medicaments | |
KR20190032461A (ko) | 경구 전달과 생물학적으로 동등한 약물동역학을 가진 경피 전달 시스템 | |
US4197318A (en) | Potentiated antimicrobial medicaments | |
WO1997035576A1 (en) | Use of isoniazid for the treatment of hyperlipoproteinemia | |
MXPA04009819A (es) | Reduccion de crecimiento de vello. | |
KR100397361B1 (ko) | 고중독성유기인신경독소,특히소만에의해야기되는중독의예방및예비치료를위한피소스티그민및스코폴아민의조합된경피투여를위한경피치료시스템및방법 | |
US4474748A (en) | Medicaments potentiated with phenyl alkanols | |
MXPA01000126A (es) | Compuesto que contiene por lo menos un principio activo que incide en el indice de grasa en la sangre. | |
JP3040427B2 (ja) | 神経痛治療用アスピリン含有軟膏組成物 | |
WO2008129000A1 (en) | Pyridopyrimidine derivatives and use thereof in the treatment of itch and itch related disorders | |
EP2570123A1 (en) | Use of 2,4-dichlorobenzyl alcohol having an anaesthetic effect | |
JP4630065B2 (ja) | 外用剤 | |
CA2038969A1 (en) | Compositions comprising cytotoxic agent and permeation enhancers | |
US20190117585A1 (en) | A device for the transdermal delivery of buprenorphine | |
CA2235617C (en) | Therapeutic preparation for the transdermal administration of active substances | |
KR0176319B1 (ko) | 알킬화제로 인한 피부 손상 치료용 조성물 | |
AU9385098A (en) | Intranasal formulation containing scopolamine and method of treating motion sickness | |
WO2009080301A1 (en) | Treatment and prevention of ischaemic cerebral lesions and cerebrovascular cognitive impairment using a treatment regimen consisting of dipyridamole and an angiotensin ii receptor blocker in patients with previous stroke | |
CA3108911A1 (en) | Compositions and methods for treatment of the side-effects associated with administration of therapeutic agents | |
JP3050917B2 (ja) | 経皮投与基剤組成物とその薬剤組成物 |